
Recommendations for using TNFα antagonists and French Clinical Practice Guidelines endorsed by the French National Authority for Health
Keywords: TNFα antagonist; Etanercept; Adalimumab; Infliximab; Golimumab; Certolizumab; Cancer; Infection; Vaccination; Pregnancy; Older patients; Surgery; Vasculitis; Paradoxical adverse events; Recommendations; French National Authority for Health (HAS)